Association between probiotic supplementation and asthma incidence in infants: a meta-analysis of randomized

Xiaochen Wei1, Ping Jiang2, Jiangbo Liu2

  • 1Department of Pharmacy, Tianjin First Central Hospital, Tianjin, People's Republic of China.

Insights

Probiotics do not significantly reduce asthma or wheeze risk in infants overall. However, they may lower wheeze incidence in infants with atopy disease.

Area of Science:

  • Pediatric Allergy and Immunology
  • Microbiome Research
  • Public Health

Background:

  • Infant asthma presents significant social and economic challenges.
  • Probiotics are explored for asthma prevention, but trial results are inconsistent.

Purpose of the Study:

  • To evaluate the efficacy of probiotic supplementation in preventing asthma and wheeze in infants through a meta-analysis of randomized controlled trials (RCTs).

Main Methods:

  • Systematic literature search of PubMed, Cochrane Library, and EMBASE databases up to August 2018.
  • Inclusion of 19 RCTs with 5157 children comparing probiotics to placebo for infant asthma/wheeze.
  • Meta-analysis using Mantel-Haenszel method to calculate risk ratios (RR) and 95% confidence intervals (CI).

Main Results:

  • Overall, probiotics showed no significant association with reduced asthma risk (RR, 0.94 [95% CI, 0.82-1.09]) or wheeze (RR, 0.97 [95% CI, 0.88-1.06]).
  • A significant reduction in wheeze incidence was observed in infants with atopy disease (RR, 0.61 [95% CI, 0.42-0.90]).
  • No significant effects were found in other subgroup analyses based on intervention details or probiotic type.

Conclusions:

  • Probiotic supplementation does not appear to lower the overall risk of asthma in infants compared to placebo.
  • Current evidence does not support recommending probiotics for infant asthma prevention, except potentially for reducing wheeze in infants with atopy.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.8K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
407
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K